Home

Piramal Pharma Ltd EPS

Image

Piramal Pharma Ltd

NSE: PPLPHARMA

EPS

₹ 0.4

Last updated on: Feb 21, 2025

Key Highlights

  • The Earning per Share of Piramal Pharma Ltd is ₹ 0.4 as of 21 Feb 25 .
  • The earning per share of Piramal Pharma Ltd changed from ₹ -0.83 to ₹ 0.03 over 7 quarters. This represents a CAGR of NaN% .

Historical Earning per Share of Piramal Pharma Ltd

No data available

* All values are in

Company Fundamentals for Piramal Pharma Ltd

Market Cap

27,655 Cr

EPS

0.4

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

3.5

Day’s High

222.65

Day’s Low

206.6

DTE

0.6

ROE

0.7

52 Week High

307.85

52 Week Low

114.45

ROCE

6.4

Market Price of Piramal Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Piramal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 2025208.6
20 Feb 2025218.05
19 Feb 2025200.45
18 Feb 2025197.65
17 Feb 2025199.85
14 Feb 2025184.8
13 Feb 2025200.9
12 Feb 2025200.2
11 Feb 2025204.35
10 Feb 2025221.1

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Piramal Pharma Ltd

Asset Value vs Market Value of Piramal Pharma Ltd

Market Value

27,655

Asset Value

Value addition

3.7 X

5,914

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Piramal Pharma Ltd27655
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

Historical Market Cap of Piramal Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Piramal Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Piramal Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Piramal Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Piramal Pharma Ltd News Hub

Piramal Pharma receives SBTi validation for its GHG commitment

Piramal Pharma has embarked on its sustainability journey as the Science Based Targets initiative (S

Read more

17 Sept 24

Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization

Read more

30 Sept 24

Piramal Pharma to discuss results

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2025. Powe

Read more

14 Jan 25

Piramal Pharma to declare Quarterly Result

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 23 October 2024. Powe

Read more

15 Oct 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Oct 2024

PPT

Sep 2024

PPT

July 2024

TranscriptPPT

Feb 2023

Transcript

Jan 2023

PPT

Nov 2022

Transcript

FAQs for EPS of Piramal Pharma Ltd

What is the EPS of Piramal Pharma Ltd stock?

The Earnings Per Share (EPS) of Piramal Pharma Ltd is 0.4. An EPS is the amount of net income attributed to each share of a common stock.

How is Piramal Pharma Ltd EPS calculated?

The EPS of Piramal Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Piramal Pharma Ltd report its EPS?

Piramal Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Piramal Pharma Ltd EPS?

Factors that influence the EPS of Piramal Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Piramal Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Piramal Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions